KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $31.1 million.

  • Idexx Laboratories' Non-Current Deffered Revenue rose 1597.88% to $31.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year increase of 1597.88%. This contributed to the annual value of $26.9 million for FY2024, which is 558.65% down from last year.
  • As of Q3 2025, Idexx Laboratories' Non-Current Deffered Revenue stood at $31.1 million, which was up 1597.88% from $31.8 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Non-Current Deffered Revenue ranged from a high of $44.2 million in Q1 2021 and a low of $26.8 million during Q3 2024
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $30.9 million (2022), whereas its average is $32.9 million.
  • Per our database at Business Quant, Idexx Laboratories' Non-Current Deffered Revenue plummeted by 2521.99% in 2021 and then surged by 1858.13% in 2025.
  • Over the past 5 years, Idexx Laboratories' Non-Current Deffered Revenue (Quarter) stood at $41.2 million in 2021, then dropped by 25.04% to $30.9 million in 2022, then decreased by 7.55% to $28.5 million in 2023, then decreased by 5.59% to $26.9 million in 2024, then rose by 15.26% to $31.1 million in 2025.
  • Its Non-Current Deffered Revenue stands at $31.1 million for Q3 2025, versus $31.8 million for Q2 2025 and $26.8 million for Q1 2025.